drugset / Trial / NCT05277311

Efficacy and Safety of LongShengZhi Capsule on Functional Recovery After Acute Ischaemic Stroke (LONGAN)

NCT05277311 ↗

Unknown 1376 enrolled Dongzhimen Hospital, Beijing
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of the study is to determine if LongShengZhi Capsule is effective and safe in patients with ischemic stroke in comparison to placebo. This trial is a prospective, multicenter, randomized, placebo-controlled, double-blinded, parallel-group, superiority trial.

Timeline

Start
2022-05-01
Primary completion
2023-12-31
Completion
2024-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject LongShengZhi Unknown — Oral

Indications